Study of Fas (CD95) and FasL (CD178) polymorphisms in liver transplant recipients
- 26 January 2006
- journal article
- Published by Wiley in Tissue Antigens
- Vol. 67 (2), 117-126
- https://doi.org/10.1111/j.1399-0039.2006.00538.x
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Fas ligand gene polymorphisms are not associated with Hashimoto’s thyroiditis and Graves’ diseaseHuman Immunology, 2003
- Evaluation of a Apo-1/Fas promoter polymorphism in Korean stroke patientsExperimental & Molecular Medicine, 2002
- Genetic polymorphisms of Fas (CD95) and FasL (CD178) in human longevity: studies on centenariansCell Death & Differentiation, 2002
- CD28/CTLA-4 and CD80/CD86 costimulatory molecules are mainly involved in acceptance or rejection of human liver transplantHuman Immunology, 2000
- The Fas and Fas ligand pathways in liver allograft toleranceClinical and Experimental Immunology, 1999
- HLA-DRB1 and -DQB1 Polymorphism in Liver Recipients: Relationship Between HLA-DQB10302 Allele Frequency and Acute RejectionHuman Immunology, 1997
- EFFECTS OF MHC-ENCODED TAP1 AND TAP2 GENE POLYMORPHISM AND MATCHING ON KIDNEY GRAFT REJECTIONTransplantation, 1995
- Acute Cellular Rejection Following Liver Transplantation: Clinical Pathologic Features and Effect on OutcomeSeminars in Liver Disease, 1992
- Treatment of Acute RejectionSeminars in Liver Disease, 1992
- Patterns of graft rejection following liver transplantationJournal of Hepatology, 1990